黛麗斯國際(00333.HK)首季實現銷售收入3.07億港元 同比減少14%
格隆匯11月18日丨黛麗斯國際(00333.HK)披露2023年財政年度第一季度經營概述,於該季度內,集團銷售收入與去年同期相比減少14%至3.07億港元,主要是由於美國主要客户受到高庫存水平和消費者需求疲軟之影響而令產品需求大幅下跌。美國市場的銷售額佔集團的銷售總額66%;歐洲市場佔20%;其餘市場佔14%。
在該季度內,東南亞廠房的海外產能比例佔全球產能的65%,而中國佔餘下的35%。客户需求的下跌主要對我們在東南亞的廠房造成影響。於該季度內,由於收入減少之影響被客户及產品組合改善所抵消,毛利率維持19%,與去年同期相若。
於該季度內,集團持資本結構及負債比率約20.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.